Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties

Citations Over TimeTop 10% of 1997 papers

Abstract

2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine, ABT-089 (S-4), a member of the 3-pyridyl ether class of nicotinic acetylcholine receptor (nAChR) ligands, shows positive effects in rodent and primate models of cognitive enhancement and a rodent model of anxiolytic activity and possesses a reduced propensity to activate peripheral ganglionic type receptors. The profiles of S-4, its N-methyl analogue, and the corresponding enantiomers across several measures of cholinergic channel function in vitro and in vivo are presented, together with in vitro metabolism and in vivo bioavailability data. On the basis of its biological activities and favorable oral bioavailability, S-4 is an attractive candidate for further evaluation as a treatment for cognitive disorders.

Related Papers

• → Chapter 7: Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation(1993)80 cited
• → The Synthesis and Storage of Acetylcholine in Mammalian Cholinergic Nerve Terminals(1988)11 cited
• → Cholinergics(2003)5 cited
• → The Non-Catalytic Role and Complex Management of Acetylcholinesterase in the Mammalian Brain Call for RNA-Based Therapies(1998)1 cited
• [Evaluation of the state of the parasympathetic branch of the autonomic nervous system by cholinergic blood activity].(1979)